Patents by Inventor Takashi KOMENO

Takashi KOMENO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PANEL
    Publication number: 20230398953
    Abstract: Provided is a panel capable of suppressing delamination of a base material and a surface material. The present invention provides a panel comprising a base material and a surface material, wherein the surface material is fixed inside a recessed part provided on the base material.
    Type: Application
    Filed: October 12, 2021
    Publication date: December 14, 2023
    Applicant: KYORAKU CO., LTD.
    Inventors: Kouichiro YOSHIDA, Yosuke HAYASHI, Takashi KOMENO, Yuki HARASAWA, Kentaro KUNIMORI
  • CORONAVIRUS INFECTION THERAPEUTIC AGENT FORMED THROUGH COMBINATION OF PYRAZINE DERIVATIVE AND ANOTHER CORONAVIRUS INFECTION THERAPEUTIC DRUG
    Publication number: 20230210848
    Abstract: An object of the present invention is to provide a novel combination of substances showing effects against coronavirus. The present invention provides a therapeutic agent for coronavirus infection comprising a combination of a pyrazine derivative or a salt thereof and another therapeutic agent for coronavirus infection.
    Type: Application
    Filed: April 27, 2021
    Publication date: July 6, 2023
    Applicant: FUJIFILM TOYAMA CHEMICAL CO., LTD.
    Inventors: Takashi KOMENO, Nozomi YAMASHITA
  • THERAPEUTIC AGENT FOR AN RNA VIRUS INFECTION COMPRISING A COMBINATION OF A PYRAZINE DERIVATIVE AND A THIOPURINE DERIVATIVE
    Publication number: 20230201238
    Abstract: The present invention addresses the problem of providing a therapeutic agent for RNA viral infection that includes a novel combination of a pyrazine derivative and a specific compound, the novel combination exhibiting an effect against the RNA virus. The present invention also addresses the problem of providing a therapeutic agent for RNA viral infection that includes a combination of a pyrazine derivative and a specific compound, the combination being capable of simultaneously enhancing anti-virus activities against multiple RNA viruses. The present invention provides a therapeutic agent for RNA viral infection obtained by combining a pyrazine derivative or a salt thereof and a thiopurine derivative.
    Type: Application
    Filed: May 26, 2021
    Publication date: June 29, 2023
    Applicant: FUJIFILM Toyama Chemical Co., Ltd.
    Inventors: Takashi KOMENO, Nozomi YAMASHITA, Chie KUROSAKI
  • Therapeutic agent for RNA viral infection comprising a combination of pyrazine derivative and compound which increases amount of pyrazine derivative ribose triphosphate in cell
    Publication number: 20220096468
    Abstract: It is an object of the present invention to provide a therapeutic agent for RNA viral infection, comprising a novel combination of a pyrazine derivative and a specific compound, which exhibits effects against an RNA virus, and also to provide a therapeutic agent for RNA viral infection, comprising a combination of a pyrazine derivative and a specific compound, which is capable of simultaneously reinforcing antiviral activities against a plurality of RNA viruses. According to the present invention, provided is a therapeutic agent for RNA viral infection, which comprises a combination of a pyrazine derivative or a salt thereof and a compound which increases the amount of a pyrazine derivative ribose triphosphate in a cell.
    Type: Application
    Filed: December 24, 2019
    Publication date: March 31, 2022
    Applicant: FUJIFILM Toyama Chemical Co., Ltd.
    Inventors: Takashi KOMENO, Toshiyuki NAKATANI, Yusuke KURIMOTO, Shun MATSUDA, Toshikazu BAN